Veterinary Antimicrobial Susceptibility Testing Market

Veterinary Antimicrobial Susceptibility Testing Market by Product (Disks, Plates, Media, Accessories, Consumables, Automated AST), Animal (Dog, Cat, Horse, Cattle, Pig, Poultry),End User (Veterinary Reference Labs, Universities) - Global Forecast to 2026

Report Code: MD 7853 Mar, 2021, by marketsandmarkets.com

[227 Pages Report] The veterinary antimicrobial susceptibility testing market is expected to reach USD 135 million by 2026 from an estimated USD 100 million in 2021, at a CAGR of 6.1%. Growth in the market is largely driven by the growing threat of antimicrobial resistance due to the overuse of antibiotics, rising demand for animal-derived products, growing prevalence of zoonotic diseases, rising demand for pet insurance, growing animal health expenditure, and the growing number of veterinary practitioners & their rising income levels in developed economies. On the other hand, the high cost of automated veterinary AST systems and rising pet care costs are expected to restrain the overall market growth to a certain extent.

Veterinary Antimicrobial Susceptibility Testing Market

To know about the assumptions considered for the study, download the pdf brochure

COVID-19 Impact on Global Veterinary Antimicrobial Susceptibility Testing Market

This pandemic has created a very low (negligible) impact on the veterinary antimicrobial susceptibility testing market as there was no such correlation between the demand for animal antimicrobial susceptibility testing in the lockdown period and post-lockdown period. It could be assumed that the COVID-19 pandemic has drastically lowered the need for antimicrobial susceptibility testing and the demand for related antimicrobial susceptibility testing products (consumables and instruments), as lockdowns reduced the number of vet visits and, hence, diagnostic testing. In this situation, it could be assumed that the demand for antimicrobial susceptibility testing products for animals reduced by 8–10% in 2020. It could be assumed that the effect of COVID-19 on the veterinary antimicrobial susceptibility testing market is negative. The lockdown reduced the number of vet visits as well as the number of ASTs performed by 20–25% (especially in quarters 1 and 2 of 2020).

Veterinary Antimicrobial Susceptibility Testing Market Dynamics

Driver: Growing threat of antimicrobial resistance due to overuse of antibiotics

The overuse of antimicrobials as growth promoters in food-producing animals (especially in the poultry and swine sectors) is a major concern worldwide. Apart from being used as growth promoters, antimicrobials are also included in animal feed as preventative prophylactic and metaphylactic treatment measures. The use of antimicrobials (as growth promoters as well as prophylactic treatment measures) is reportedly higher in healthy animals than in sick animals. According to the WHO, approximately 80% of all antibiotics manufactured worldwide are used in livestock animals. The easy availability of antimicrobials from feed suppliers is a major reason for its overuse. Antimicrobial overuse, however, increases the risk of antimicrobial resistance (AMR), which leads to serious clinical and economic implications. Government and regulatory bodies have also designed antimicrobial stewardship programs to increase awareness in veterinarians, livestock farmers, and pet owners. These programs recommend restricting the use of antimicrobials as growth promoters in livestock animals and promote the adoption of antimicrobial susceptibility tests before prescribing commonly used antibiotics for sick animals.

Restraint: High cost of automated veterinary antimicrobial susceptibility testing systems

One of the main drawbacks of traditional or manual veterinary antimicrobial susceptibility testing methods (such as agar dilution, chromogenic agar method, disk diffusion, and micro-broth dilution) is the time taken to obtain the results, which can vary from 24 to 48 hours. Automated veterinary antimicrobial susceptibility testing systems provide rapid results with better accuracy and fewer chances of human error. However, the adoption of these systems in veterinary laboratories is limited, especially in developing countries due to their high cost. Moreover, expensive reagents and consumables are used for these systems, along with additional costs incurred for trained personnel. This increases the overall test cost. The high cost of these diagnostic tests is one of the major reasons for the low adoption in developed as well as developing countries. Since the volumes of veterinary samples received for testing are generally small, veterinary diagnostic laboratories do not prefer to invest in expensive systems. Most veterinary practices are small or medium-sized, with strict budgetary constraints; the high cost of these systems is, therefore, a major market restraint.

Opportunity: Rising focus on veterinary antimicrobial susceptibility testing in emerging markets due to supportive government initiatives

Companion animal ownership has grown significantly across the globe. This is particularly evident in emerging markets in the APAC and Latin American countries due to urbanization and an increase in disposable incomes—which have expanded access to animal healthcare and enabled owners to spend more on pet care. Emerging countries like India and China have robust livestock markets. According to the Livestock Production Statistics of India 2018, India is one of the largest milk producers followed by the US, China, Brazil, and Pakistan. According to the USDA Foreign Agricultural Service in 2017, China is the fourth-largest beef producer in the world. According to the FAO, China was also the world’s largest hog producer and pork consumer.  Milk consumption in China is also increasing at a rapid pace. To provide quality animal-derived food products, various animal healthcare products are used to prevent and control diseases in livestock animals. This increasing government focus and efforts to promote the appropriate usage of antibiotics in emerging countries has increased the number of clinical diagnostic procedures carried out, which, in turn, would increase the sales of AST products in these regions. The emerging economies are expected to become a focal point for the growth of the veterinary antimicrobials susceptibility testing market. The Asia Pacific, Middle Eastern, and Latin American regions are relatively untapped markets for companies compared to Europe and North America. Growth in these untapped markets is supported by various initiatives by government organizations to combat veterinary antibiotic resistance.

Challenge: Low awareness about antimicrobial resistance in veterinarians and livestock farmers

The major driver for antibiotic resistance is widespread antibiotic use, including appropriative and inappropriate use. The Centers for Disease Control and Prevention (CDC) reports that up to 50% of all antibiotics in outpatient healthcare are unnecessarily or incorrectly prescribed. To reduce the inappropriate use of antibiotics, various associations and regulatory bodies have published guidelines for the use of antimicrobials. For instance, the International Society of Companion Animal Infectious Diseases (ISCAID) has published antibiotic guidelines for three disease syndromes—canine pyoderma, canine and feline urinary tract infections, and canine and feline respiratory diseases. Culture and sensitivity testing is an important diagnostic tool that provides information about infection etiology and resistance profiles. However, awareness regarding the importance of these diagnostic tests and AMR in veterinarians in developed as well as developing countries is very low. According to a Washington State Study report (a survey of veterinary antimicrobial prescribing practices in Washington State 2015), almost 25% of veterinarians in Washington state (US) are not currently using AST, and the remaining 75% of veterinarians use it less than 75% of the time.

North America is expected to account for the largest share of the veterinary antimicrobial susceptibility testing market in 2020

In 2020, North America accounted for the largest share of the global veterinary antimicrobial susceptibility testing market. The US accounted for the largest share of the North American veterinary antimicrobial susceptibility testing market. The veterinary antimicrobial susceptibility testing market in North America is characterized by the increasing population of companion and food-producing animals, rising meat and dairy product consumption, the availability of technologically advanced veterinary reference laboratories, strict guidelines for usage of antimicrobials, rising veterinary healthcare expenditure, and growth in pet insurance coverage.

Veterinary Antimicrobial Susceptibility Testing Market  by Region

Key Market Players

The prominent players in this market are BioMιrieux SA (France), Thermo Fisher Scientific (US), Bruker Corporation (US), Danaher Corporation (US), Becton, Dickinson and Company (US), Synbiosis (UK), Liofilchem S.r.l. (Italy), and HiMedia Laboratories (India) are the leading players in the veterinary antimicrobial susceptibility testing market. Bio-Rad Laboratories (US), Neogen Corporation (US), Mast Group Ltd. (UK), Condalab (Spain), FASTinov (Portugal), Hardy Diagnostics (US), Bioguard Corporation (Taiwan), and SSI Diagnostica A/S (Denmark).

Scope of the report

Report Metric

Details

Market size available for years

2019–2026

Base year considered

2020

Forecast period

2021–2026

Forecast units

Value (USD Million)

Segments covered

By Product, Animal Type, End User

Geographies covered

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa

Companies covered

BioMιrieux SA (France), Thermo Fisher Scientific (US), Bruker Corporation (US), Danaher Corporation (US), Becton, Dickinson and Company
(US), Synbiosis (UK), Liofilchem S.r.l. (Italy), HiMedia Laboratories (India), Bio-Rad Laboratories (US), Neogen Corporation (US), Mast Group Ltd. (UK), Condalab (Spain), FASTinov (Portugal), Hardy Diagnostics (US), Bioguard Corporation (Taiwan), and SSI Diagnostica A/S (Denmark)

The study categorizes the Veterinary Antimicrobial Susceptibility Market based on animal type, by product, end user, and regional and global level.

Global Veterinary Antimicrobial Susceptibility Testing Market, by Product Type                                   

  • Disks and Plates
  • Culture Media
  • Accessories & Consumables
  • Automated AST Instruments

Global Veterinary Antimicrobial Susceptibility Testing Market, by Animal Type     

  • Food-producing Animals
  • Cattle
  • Pigs
  • Poultry
  • Other Food-producing Animals
  • Companion Animals
  • Dogs
  • Cats
  • Horses
  • Other Companion Animals

Global Veterinary Antimicrobial Susceptibility Testing Market, by End User            

  • Veterinary Reference Laboratory
  • Veterinary Research Institutes and Universities
  • Other End Users

Global Veterinary Antimicrobial Susceptibility Testing Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of APAC
  • Latin America
  • Middle East & Africa

Recent Developments

  • In 2020, Becton, Dickinson and Company  (US) announced collaboration with Fleming Fund Aid Program to help low- and middle-income countries tackle AMR and increase awareness about AST.
  • In 2019, Synbiosis (UK) launched AutoCol, an automated colony counter system.
  • In 2018, Thermo Fisher Scientific (US) launche AST Plates Zactran to detect respiratory diseases in cattle.
  • In 2017, Bruker Corporation (US) accquired Merlin Diagnostika to add selected antibiotic resistance and susceptibility testing products to its MALDI Biotyper Microbial Identification Platform.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 30)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
           1.3.3 CURRENCY
           1.3.4 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
    1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 33)
    2.1 RESEARCH DATA
           FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
           FIGURE 2 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
           FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,  AND REGION
    2.2 MARKET SIZE ESTIMATION
           FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
           FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION: BIOMΙRIEUX
           FIGURE 6 REVENUE ANALYSIS OF TOP 5 COMPANIES: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET (2020)
           FIGURE 7 DEMAND-SIDE ANALYSIS
           FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
           FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET (2021–2026)
           FIGURE 10 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN & DATA TRIANGULATION
           FIGURE 11 MARKET DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ANALYSIS
    2.5 ASSUMPTIONS FOR THE STUDY
    2.6 LIMITATIONS/RISK ASSESSMENT
    2.7 COVID-19 HEALTH ASSESSMENT
    2.8 COVID-19 ECONOMIC ASSESSMENT
    2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
           FIGURE 12 CRITERIA IMPACTING THE GLOBAL ECONOMY
           FIGURE 13 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
    2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET

3 EXECUTIVE SUMMARY (Page No. - 50)
           FIGURE 14 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2021 VS. 2026
           FIGURE 15 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2021 VS. 2026
           FIGURE 16 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2021 VS. 2026
           FIGURE 17 GEOGRAPHIC SNAPSHOT: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET

4 PREMIUM INSIGHTS (Page No. - 54)
    4.1 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET OVERVIEW
           FIGURE 18 GROWING ANIMAL POPULATION AND INCREASING ANIMAL HEALTHCARE EXPENDITURE ARE KEY FACTORS DRIVING MARKET GROWTH
    4.2 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT
           FIGURE 19 DISKS & PLATES COMMANDED THE LARGEST SHARE OF THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET IN 2020
    4.3 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: GEOGRAPHIC MIX
           FIGURE 20 CHINA TO WITNESS THE HIGHEST GROWTH IN THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 57)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 21 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 MARKET DRIVERS
                    5.2.1.1 Growing threat of antimicrobial resistance due to overuse of antibiotics
           FIGURE 22 SALES AND DISTRIBUTION OF ANTIMICROBIAL DRUGS APPROVED FOR USE IN FOOD-PRODUCING ANIMALS IN THE US (2010–2019)
                    5.2.1.2 Rising demand for animal-derived food products
           TABLE 1 PAST AND PROJECTED TRENDS IN THE CONSUMPTION OF MEAT AND MILK IN DEVELOPED AND DEVELOPING REGIONS
           TABLE 2 SIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS,  2020 VS. 2030 (THOUSAND METRIC TONS)
           TABLE 3 ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS,  2020 VS. 2030 (THOUSAND METRIC TONS)
           FIGURE 23 ASIA WAS THE HIGHEST CONSUMER OF MEAT AND MILK IN THE WORLD 2018
                    5.2.1.3 Growing prevalence of zoonotic diseases
           TABLE 4 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2019)
                    5.2.1.4 Rising demand for pet insurance and growing animal health expenditure
           FIGURE 24 US: PET INDUSTRY EXPENDITURE, 2010–2019
                    5.2.1.5 Growing number of veterinary practitioners & their rising income levels in developed economies
           TABLE 5 NUMBER OF VETERINARIANS AND PARA-VETERINARIANS IN DEVELOPED COUNTRIES, 2012–2018
           TABLE 6 MARKET DRIVERS: IMPACT ANALYSIS
           5.2.2 MARKET RESTRAINTS
                    5.2.2.1 High cost of automated veterinary antimicrobial susceptibility testing systems
                    5.2.2.2 Rising pet care costs
           TABLE 7 MARKET RESTRAINTS: IMPACT ANALYSIS
           5.2.3 MARKET OPPORTUNITIES
                    5.2.3.1 Rising focus on veterinary antimicrobial susceptibility testing in emerging markets due to supportive government initiatives
                    5.2.3.2 Growth in the companion animal population
           TABLE 8 PET POPULATION, BY ANIMAL, 2014–2018 (MILLION)
           TABLE 9 MARKET OPPORTUNITY: IMPACT ANALYSIS
           5.2.4 MARKET CHALLENGES
                    5.2.4.1 Low awareness about antimicrobial resistance in veterinarians and livestock farmers
                    5.2.4.2 Limited guidelines for interpretation of veterinary antimicrobial susceptibility test results
                    5.2.4.3 Shortage of veterinary practitioners and skilled veterinary pathologists in developing markets
           TABLE 10 NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY, 2005 VS. 2014 VS. 2018
           TABLE 11 MARKET CHALLENGES: IMPACT ANALYSIS
    5.3 TECHNOLOGICAL ANALYSIS
           FIGURE 25 TECHNOLOGICAL ADVANCEMENTS ARE A MAJOR TREND IN THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
    5.4 PRICING ANALYSIS
           TABLE 12 REGIONAL PRICING ANALYSIS OF AUTOMATED AST INSTRUMENTS, 2019 (USD)
    5.5 VALUE CHAIN ANALYSIS
           FIGURE 26 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: VALUE CHAIN ANALYSIS
    5.6 ECOSYSTEM MARKET MAP
           FIGURE 27 VETERINARY ANTIMICROBIAL SENSITIVITY TESTING MARKET: ECOSYSTEM MARKET MAP
           FIGURE 28 VETERINARY ANTIMICROBIAL SENSITIVITY TESTING MARKET: ECOSYSTEM MARKET MAP
    5.7 PORTER’S FIVE FORCES ANALYSIS
           TABLE 13 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.7.1 THREAT FROM NEW ENTRANTS
           5.7.2 INTENSITY OF COMPETITIVE RIVALRY
           5.7.3 BARGAINING POWER OF BUYERS
           5.7.4 BARGAINING POWER OF SUPPLIERS
           5.7.5 THREAT FROM SUBSTITUTES
    5.8 SUPPLY CHAIN ANALYSIS
           FIGURE 29 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: SUPPLY CHAIN ANALYSIS
    5.9 IMPACT OF COVID-19 ON THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
    5.10 REGULATORY ANALYSIS
    5.11 PATENT ANALYSIS
           5.11.1 PATENT PUBLICATION TRENDS FOR VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING INSTRUMENTS
           FIGURE 30 PATENT PUBLICATION TRENDS (2015–2020)
           5.11.2 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING INSTRUMENTS
           FIGURE 31 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING INSTRUMENTS (2015–2021)
    5.12 DIFFERENCE BETWEEN 96-WELL PLATES AND 384-WELL PLATES
           TABLE 14 DIFFERENCE BETWEEN 96-WELL PLATES AND 384-WELL PLATES
    5.13 CUSTOMIZED VS. PORTFOLIO PRODUCTS

6 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT (Page No. - 83)
    6.1 INTRODUCTION
           TABLE 15 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT,  2019–2026 (USD MILLION)
    6.2 DISKS & PLATES
           6.2.1 DISKS & PLATES ACCOUNTED FOR THE LARGEST SHARE OF THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET IN 2020
           TABLE 16 LEADING DISKS & PLATES AVAILABLE IN THE MARKET FOR VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING (2020)
           TABLE 17 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR DISKS & PLATES,  BY COUNTRY, 2019–2026 (USD MILLION)
    6.3 CULTURE MEDIA
           6.3.1 CONSTANT REQUIREMENT AND REPETITIVE PURCHASE OF CULTURE MEDIA TO DRIVE MARKET GROWTH
           TABLE 18 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR CULTURE MEDIA,  BY COUNTRY, 2019–2026 (USD MILLION)
    6.4 ACCESSORIES & CONSUMABLES
           6.4.1 WIDE USE OF MANUAL METHODS LIKE DISK DIFFUSION WILL DRIVE THE GROWTH OF THIS SEGMENT
           TABLE 19 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR ACCESSORIES & CONSUMABLES, BY COUNTRY, 2019–2026 (USD MILLION)
    6.5 AUTOMATED AST INSTRUMENTS
           6.5.1 ONGOING TREND OF LABORATORY AUTOMATION TO DRIVE GROWTH IN THIS MARKET SEGMENT
           TABLE 20 ADVANTAGES OF AUTOMATED AST OVER DISKS & PLATES
           TABLE 21 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR AUTOMATED AST INSTRUMENTS, BY COUNTRY, 2019–2026 (USD MILLION)

7 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE (Page No. - 91)
    7.1 INTRODUCTION
           TABLE 22 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE,  2019–2026 (USD MILLION)
    7.2 FOOD-PRODUCING ANIMALS
           FIGURE 32 MARKET FOR CATTLE TO DOMINATE THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS DURING THE FORECAST PERIOD
           TABLE 23 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 24 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
           7.2.1 CATTLE
                    7.2.1.1 Increasing cattle population and growing consumption of meat to drive growth in the veterinary AST market
           TABLE 25 EXAMPLES OF CATTLE-RELATED AMR HUMAN HEALTH THREATS
           TABLE 26 CATTLE POPULATION, BY COUNTRY, 2012–2019 (MILLION)
           TABLE 27 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR CATTLE,  BY COUNTRY, 2019–2026 (USD MILLION)
           7.2.2 PIGS
                    7.2.2.1 Growing incidence of infectious diseases will  support market growth
           TABLE 28 SWINE POPULATION, BY COUNTRY, 2012–2019 (MILLION)
           FIGURE 33 PER CAPITA PORK CONSUMPTION, 2006–2018 (POUNDS)
           TABLE 29 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR PIGS, BY COUNTRY, 2019–2026 (USD MILLION)
           7.2.3 POULTRY
                    7.2.3.1 Growing infectious disease prevalence in poultry will support the growth of the veterinary antimicrobial susceptibility testing market
           FIGURE 34 PER CAPITA POULTRY MEAT CONSUMPTION, 2006–2018 (POUNDS)
           TABLE 30 POULTRY POPULATION, BY COUNTRY, 2012–2019 (MILLION)
           TABLE 31 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR POULTRY,  BY COUNTRY, 2019–2026 (USD MILLION)
           7.2.4 OTHER FOOD-PRODUCING ANIMALS
           TABLE 32 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR OTHER FOOD-PRODUCING ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
    7.3 COMPANION ANIMALS
           TABLE 33 POPULATION OF DOGS AND CATS, BY COUNTRY, 2012–2019 (MILLION)
           FIGURE 35 MARKET FOR DOGS TO REGISTER THE HIGHEST GROWTH IN THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS DURING THE FORECAST PERIOD
           TABLE 34 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 35 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
           7.3.1 DOGS
                    7.3.1.1 Dogs dominate the veterinary antimicrobial susceptibility testing market for companion animals
           TABLE 36 DOG POPULATION, BY COUNTRY, 2012–2019 (MILLION)
           TABLE 37 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR DOGS, BY COUNTRY, 2019–2026 (USD MILLION)
           7.3.2 CATS
                    7.3.2.1 Increasing pet cat population to drive market growth
           TABLE 38 CAT POPULATION, BY COUNTRY, 2012–2019 (MILLION)
           TABLE 39 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR CATS, BY COUNTRY, 2019–2026 (USD MILLION)
           7.3.3 HORSES
                    7.3.3.1 Growing equine health awareness will drive the market growth
           TABLE 40 EQUINE POPULATION, BY COUNTRY, 2012–2019 (THOUSAND)
           TABLE 41 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR HORSES,  BY COUNTRY, 2019–2026 (USD MILLION)
           7.3.4 OTHER COMPANION ANIMALS
           TABLE 42 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)

8 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER (Page No. - 111)
    8.1 INTRODUCTION
           TABLE 43 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER,  2019–2026 (USD MILLION)
    8.2 VETERINARY REFERENCE LABORATORIES
           8.2.1 VETERINARY REFERENCE LABORATORIES ARE THE LARGEST END USERS OF VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTS
           TABLE 44 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR VETERINARY REFERENCE LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)
    8.3 VETERINARY RESEARCH INSTITUTES AND UNIVERSITIES
           8.3.1 INCREASING FUNDING FOR RESEARCH ON ANTIMICROBIAL RESISTANCE AND AST IN UNIVERSITIES TO BOOST MARKET GROWTH
           TABLE 45 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR VETERINARY RESEARCH INSTITUTES AND UNIVERSITIES, BY COUNTRY, 2019–2026 (USD MILLION)
    8.4 OTHER END USERS
           TABLE 46 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)

9 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION (Page No. - 116)
    9.1 INTRODUCTION
           FIGURE 36 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
           TABLE 47 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION,  2019–2026 (USD MILLION)
    9.2 NORTH AMERICA
           FIGURE 37 EXPECTED GROWTH IN THE NUMBER OF VETERINARIANS IN NORTH AMERICA
           FIGURE 38 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SNAPSHOT
           TABLE 48 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 49 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,  BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 50 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,  BY ANIMAL TYPE, 2019–2026 (USD MILLION)
           TABLE 51 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 52 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 53 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,  BY END USER, 2019–2026 (USD MILLION)
           9.2.1 US
                    9.2.1.1 The US dominated the North American veterinary antimicrobial susceptibility testing market in 2020
           FIGURE 39 US: EXPENDITURE ON VET VISITS
           FIGURE 40 US: NUMBER OF VETERINARIANS, 2014–2019
           TABLE 54 US: FOOD-PRODUCING ANIMAL POPULATION, 2001–2019 (MILLION)
           FIGURE 41 DOMESTIC SALES AND DISTRIBUTION OF MEDICALLY IMPORTANT ANTIMICROBIAL DRUGS FOR PRODUCTION AND THERAPEUTIC INDICATIONS IN THE US (THOUSAND KG)
           TABLE 55 US: NUMBER OF VETERINARIANS IN PRIVATE CLINICAL PRACTICES, 2014 VS. 2019
           TABLE 56 US: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 57 US: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
           TABLE 58 US: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 59 US: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 60 US: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Slow economic growth in Canada severely affects its share in the North American Market
           TABLE 61 CANADA: LARGE ANIMAL POPULATION, 2001–2014 (MILLION)
           TABLE 62 CANADA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 63 CANADA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
           TABLE 64 CANADA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 65 CANADA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 66 CANADA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.3 EUROPE
           TABLE 67 EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 68 EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 69 EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
           TABLE 70 EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 71 EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 72 EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.1 UK
                    9.3.1.1 The UK is the largest market for veterinary antimicrobial susceptibility testing in Europe
           FIGURE 42 SALES OF ANTIBIOTICS FOR FOOD-PRODUCING ANIMALS IN THE UK FROM  2015 TO 2019 (MG/KG)
           TABLE 73 UK: PET POPULATION, 2016–2019 (MILLION)
           FIGURE 43 NUMBER OF PRACTICING VETERINARIANS IN THE UK, 2013–2017
           TABLE 74 UK: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 75 UK: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
           TABLE 76 UK: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 77 UK: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 78 UK: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.2 GERMANY
                    9.3.2.1 Strict government regulations for AST to drive market growth in Germany
           FIGURE 44 SALES SURVEILLANCE OF ANTIMICROBIALS FOR VETERINARY USE IN GERMANY (2011–2018)
           TABLE 79 GERMANY: PET POPULATION, 2012–2019 (MILLION)
           TABLE 80 GERMANY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 81 GERMANY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
           TABLE 82 GERMANY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 83 GERMANY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 84 GERMANY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,  BY END USER, 2019–2026 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Mandatory AST before prescribing antibiotics in animals to drive market growth
           TABLE 85 FRANCE: COMPANION ANIMAL POPULATION, 2010–2019 (MILLION)
           TABLE 86 FRANCE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 87 FRANCE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
           TABLE 88 FRANCE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 89 FRANCE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 90 FRANCE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Increasing food-producing animal population and growing awareness of AMR will generate high demand for AST in Italy
           TABLE 91 ITALY: LARGE ANIMAL POPULATION, 2001–2019 (MILLION)
           TABLE 92 ITALY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 93 ITALY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,BY ANIMAL TYPE, 2019–2026 (USD MILLION)
           TABLE 94 ITALY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 95 ITALY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 96 ITALY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.5 SPAIN
                    9.3.5.1 Increasing demand for good quality animal-based food products is a major factor driving market growth
           TABLE 97 SPAIN: LARGE ANIMAL POPULATION, 2001–2019 (MILLION)
           TABLE 98 SPAIN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 99 SPAIN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
           TABLE 100 SPAIN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 101 SPAIN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 102 SPAIN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.6 REST OF EUROPE (ROE)
           TABLE 103 COMPANION ANIMAL OWNERSHIP IN THE REST OF EUROPE, 2018 (MILLION)
           TABLE 104 REST OF EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,  BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 105 REST OF EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
           TABLE 106 REST OF EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 107 REST OF EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 108 REST OF EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,  BY END USER, 2019–2026 (USD MILLION)
    9.4 ASIA PACIFIC (APAC)
           TABLE 109 APAC: FOOD-PRODUCING ANIMAL POPULATION, 2010–2018 (MILLION)
           FIGURE 45 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SNAPSHOT
           TABLE 110 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,  BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 111 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,  BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 112 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,  BY ANIMAL TYPE, 2019–2026 (USD MILLION)
           TABLE 113 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 114 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 115 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.1 CHINA
                    9.4.1.1 China dominated the APAC veterinary antimicrobial susceptibility testing market in 2020
           TABLE 116 CHINA: FOOD-PRODUCING ANIMAL POPULATION, 2012–2019 (MILLION)
           TABLE 117 CHINA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 118 CHINA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
           TABLE 119 CHINA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 120 CHINA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 121 CHINA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.2 JAPAN
                    9.4.2.1 Increasing risk of AMR due to high use of antimicrobial feed additives drives the market growth in Japan
           FIGURE 46 VOLUME OF VETERINARY ANTIMICROBIALS SOLD BY PHARMACEUTICAL COMPANIES IN JAPAN, 2001–2017 (IN TONS OF ACTIVE INGREDIENT)
           FIGURE 47 AMOUNT OF ANTIMICROBIAL FEED ADDITIVES MANUFACTURED IN JAPAN, 2003–2017 (IN TONS OF ACTIVE INGREDIENT)
           TABLE 122 JAPAN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 123 JAPAN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
           TABLE 124 JAPAN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 125 JAPAN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 126 JAPAN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 Rising food-producing animal population and growing awareness about animal health will contribute to market growth during the forecast period
           TABLE 127 INDIA: FOOD-PRODUCING ANIMAL POPULATION, 2010–2019 (MILLION)
           TABLE 128 INDIA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 129 INDIA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
           TABLE 130 INDIA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 131 INDIA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 132 INDIA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.4 ROAPAC
           TABLE 133 REST OF ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 134 REST OF ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
           TABLE 135 REST OF ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 136 REST OF ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 137 REST OF ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.5 LATIN AMERICA
           9.5.1 INCREASING BEEF AND POULTRY MEAT EXPORTS SUPPORTS THE MARKET GROWTH
           TABLE 138 LATIN AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,  BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 139 LATIN AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,  BY ANIMAL TYPE, 2019–2026 (USD MILLION)
           TABLE 140 LATIN AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 141 LATIN AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 142 LATIN AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,  BY END USER, 2019–2026 (USD MILLION)
    9.6 MIDDLE EAST & AFRICA
           9.6.1 AVAILABILITY OF FUNDING TO PROMOTE ANIMAL HEALTHCARE IN THIS REGION SUPPORTS OVERALL MARKET GROWTH
           TABLE 143 MIDDLE EAST: NUMBER OF VETERINARIANS AND PARAVETERINARIANS, BY COUNTRY (2016 VS. 2018)
           TABLE 144 AFRICA: NUMBER OF VETERINARIANS, 2010 VS. 2014 VS. 2016
           TABLE 145 MIDDLE EAST & AFRICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 146 MIDDLE EAST & AFRICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
           TABLE 147 MIDDLE EAST & AFRICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 148 MIDDLE EAST & AFRICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 149 MIDDLE EAST & AFRICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 173)
     10.1 KEY PLAYER STRATEGIES
           FIGURE 48 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN 2017 AND 2021 (JANUARY)
     10.2 MARKET EVALUATION FRAMEWORK
           FIGURE 49 MARKET EVALUATION FRAMEWORK: MARKET CONSOLIDATION THROUGH PARTNERSHIPS, COLLABORATIONS, ACQUISITIONS, AND AGREEMENTS
     10.3 REVENUE ANALYSIS
           FIGURE 50 REVENUE ANALYSIS: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, 2020
     10.4 MARKET SHARE ANALYSIS
           FIGURE 51 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
           TABLE 150 COMPETITION ANALYSIS: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, 2020
     10.5 COMPANY EVALUATION QUADRANT/DIVE MATRIX
             10.5.1 STARS
             10.5.2 EMERGING LEADERS
             10.5.3 PERVASIVE PLAYERS
             10.5.4 PARTICIPANTS
           FIGURE 52 COMPANY EVALUATION QUADRANT/DIVE MATRIX: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
           FIGURE 53 COMPANY PRODUCT FOOTPRINT: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
     10.6 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: GEOGRAPHICAL ASSESSMENT
           FIGURE 54 GEOGRAPHIC ASSESSMENT OF KEY PLAYERS IN THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET (2020)
     10.7 COMPETITIVE SITUATION AND TRENDS
             10.7.1 PRODUCT LAUNCHES & ENHANCEMENTS
           TABLE 151 PRODUCT LAUNCHES & ENHANCEMENTS (2017 – JANUARY 2021)
             10.7.2 DEALS
           TABLE 152 DEALS (2017–JANUARY 2021)

11 COMPANY PROFILES (Page No. - 182)
     11.1 SUPPLY-SIDE PLAYERS
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)* 
             11.1.1 THERMO FISHER SCIENTIFIC INC.
           TABLE 153 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
           FIGURE 55 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC (2019)
             11.1.2 BECTON, DICKINSON AND COMPANY
           TABLE 154 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
           FIGURE 56 COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY (2020)
             11.1.3 BRUKER CORPORATION
           TABLE 155 BRUKER CORPORATION: BUSINESS OVERVIEW
           FIGURE 57 COMPANY SNAPSHOT: BRUKER CORPORATION (2019)
             11.1.4 BIOMΙRIEUX SA.
           TABLE 156 BIOMΙRIEUX: BUSINESS OVERVIEW
           FIGURE 58 COMPANY SNAPSHOT: BIOMΙRIEUX S.A. (2019)
             11.1.5 DANAHER CORPORATION
           TABLE 157 DANAHER CORPORATION: BUSINESS OVERVIEW
           FIGURE 59 COMPANY SNAPSHOT: DANAHER CORPORATION (2019)
             11.1.6 BIO-RAD LABORATORIES, INC.
           TABLE 158 BIO-RAD LABORATORIES: BUSINESS OVERVIEW
           FIGURE 60 COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC. (2020)
             11.1.7 NEOGEN CORPORATION
           TABLE 159 NEOGEN CORPORATION: BUSINESS OVERVIEW
           FIGURE 61 COMPANY SNAPSHOT: NEOGEN CORPORATION (2020)
             11.1.8 HIMEDIA LABORATORIES
           TABLE 160 HIMEDIA LABORATORIES: BUSINESS OVERVIEW
             11.1.9 MAST GROUP LTD.
           TABLE 161 MAST GROUP LTD.: BUSINESS OVERVIEW
             11.1.10 BIOGUARD CORPORATION
           TABLE 162 BIOGUARD CORPORATION: BUSINESS OVERVIEW
             11.1.11 SSI DIAGNOSTICA A/S
           TABLE 163 SSI DIAGNOSTICA A/S: BUSINESS OVERVIEW
             11.1.12 CONDALAB
           TABLE 164 CONDALAB: BUSINESS OVERVIEW
             11.1.13 FASTINOV SA
           TABLE 165 FASTINOV SA: BUSINESS OVERVIEW
             11.1.14 SYNBIOSIS
           TABLE 166 SYNBIOSIS: BUSINESS OVERVIEW
             11.1.15 HARDY DIAGNOSTICS
           TABLE 167 HARDY DIAGNOSTICS: BUSINESS OVERVIEW
             11.1.16 LIOFILCHEM SRL.
           TABLE 168 LIOFILCHEM SRL: BUSINESS OVERVIEW
     11.2 DEMAND-SIDE PLAYERS
             11.2.1 IDEXX REFERENCE LABORATORIES
           TABLE 169 IDEXX LABORATORIES, INC.: BUSINESS OVERVIEW
           FIGURE 62 COMPANY SNAPSHOT: IDEXX LABORATORIES, INC. (2020)
             11.2.2 UNIVERSITY OF MINNESOTA (VETERINARY DIAGNOSTIC LABORATORY)
             11.2.3 IOWA STATE UNIVERSITY (VETERINARY DIAGNOSTIC LABORATORY)
             11.2.4 CORNELL UNIVERSITY (ANIMAL HEALTH DIAGNOSTIC CENTER)
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies. 

12 APPENDIX (Page No. - 219)
     12.1 DISCUSSION GUIDE
     12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     12.3 AVAILABLE CUSTOMIZATIONS
     12.4 RELATED REPORTS
     12.5 AUTHOR DETAILS

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

This research study involved the usage of comprehensive secondary sources; directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for an extensive, technical, market-oriented, and commercial study of the veterinary antimicrobial susceptibility testing market. It was also used to obtain important information about the key players, market classification and segmentation according to industry trends to the bottommost level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side and demand side are detailed below.

Veterinary Antimicrobial Susceptibility Testing Market   Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the veterinary antimicrobial susceptibility testing market was arrived at after data triangulation from four different approaches (Supply-side Analysis (Revenue Share Analysis), Parent Market Approach, Company Presentations, Primary Interviews and Demand-side Analysis). After each approach, the weighted average of the four approaches was taken based on the level of assumptions used in each approach.

Data Triangulation

After arriving at the market size, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The following figure shows the market validation, source structure, and data triangulation methodology implemented in this report’s market engineering process.

Objectives of the Study

  • To define, describe, and forecast the global veterinary antimicrobial susceptibility testing market based on product, animal type, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyse micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall veterinary antimicrobial susceptibility testing market
  • To analyse the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the global veterinary antimicrobial susceptibility testing market with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
  • To strategically profile the key players in the global veterinary antimicrobial susceptibility testing market and comprehensively analyse their core competencies2 and market shares
  • To track and analyse competitive developments such as product launches, acquisitions, and partnerships in the veterinary antimicrobial susceptibility testing market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

Geographic Analysis

  • Further breakdown of the Rest of Asia Pacific veterinary antimicrobial susceptibility testing market into South Korea, Australia, New Zealand, and others
  • Further breakdown of the Rest of Europe veterinary antimicrobial susceptibility testing market into Belgium, Russia, the Netherlands, Switzerland, and others
  • Further breakdown of the Latin American veterinary antimicrobial susceptibility testing market into Brazil, Mexico, and the Rest of Latin America
COVID-19

Get in-depth analysis of the COVID-19 impact on the Veterinary Antimicrobial Susceptibility Testing Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Veterinary Antimicrobial Susceptibility Testing Market

Request For Special Pricing
Report Code
MD 7853
Published ON
Mar, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Veterinary Antimicrobial Susceptibility Testing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home